About Nuevolution
Nuevolution is a company based in Copenhagen (Denmark) founded in 2001 was acquired by Amgen in May 2019. Nuevolution has raised $12.45 million across 2 funding rounds from investors including Amgen, SEB and Sunstone. Nuevolution operates in a competitive market with competitors including Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.
- Headquarter Copenhagen, Denmark
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Nuevolution
Nuevolution has successfully raised a total of $12.45M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.45 million completed in June 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nuevolution
Nuevolution has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, SEB and Sunstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by Sunstone in early-stage European companies.
|
Locked | Locked | Locked | |
|
Investments in deep-tech, life sciences, and transformative tech are managed.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Nuevolution
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nuevolution
Investment portfolio details for Nuevolution
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nuevolution
Detailed financials for Nuevolution
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nuevolution Comparisons
Peer comparison for Nuevolution
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nuevolution
Nuevolution operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
Detailed competitors of Nuevolution
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nuevolution
Complete news archive for Nuevolution
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nuevolution
Nuevolution was founded in 2001 and raised its 1st funding round 2 years after it was founded.
Nuevolution is headquartered in Copenhagen, Denmark.
Nuevolution is a funded company, having raised a total of $12.45M across 2 funding rounds to date.
Founded in 2001 and based in Copenhagen, Denmark, drug treatments targeting oncology and chronic inflammatory diseases are developed by the company. Operations focus on biotechnology, utilizing Chemics technology for synthesizing Chemetics molecules that combine drugs, DNA tags, and linkers. High-throughput screening identifies active compounds, followed by optimization from hit identification to lead stages. The domain nuevolution.com supports these activities in the pharmaceutical sector.
Nuevolution's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Nuevolution has 6 investors. Key investors include Amgen, SEB, Sunstone, Industrifonden, and SLS Venture.